Dario Altieri named CEO of The Wistar Institute

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

DARIO ALTIERI was named CEO of The Wistar Institute, following the announced retirement of President and CEO Russel Kaufman, effective March 2. Altieri will continue to serve as director of the Wistar Cancer Center, and Kaufman will become president emeritus.

Altieri also serves as Wistar’s executive vice president, chief scientific officer and the Robert and Penny Fox Distinguished Professor. He joined Wistar in 2010.

Kaufman joined Wistar in 2002 from Duke University School of Medicine where he was vice dean for Education and Academic Affairs as well as chancellor for Academic Affairs for the Duke University Health System.

Kaufman led the institute during its ongoing $35 million capital campaign, which began in 2010. The campaign supported Wistar’s first major building project since 1976, the Robert and Penny Fox Tower. According to the institute, Wistar has raised close to $80 million during Kaufman’s nearly 13 years.

YOU MAY BE INTERESTED IN

With the recent FDA approval of daratumumab for high-risk smoldering multiple myeloma, the moment is ripe to revisit the evolution of our understanding of smoldering multiple myeloma. This development not only underscores the growing recognition of early intervention but also invites a broader reflection on the biological insights and therapeutic strategies that have shaped—and continue to shape—this transitional disease state.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login